{"schema_version":"secwatch.filing_event.v1","accession":"0001818093-22-000177","form_type":"8-K","ticker":"SKIN","cik":"0001818093","company_name":"SkinHealth Systems Inc.","filed_at":"2022-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.293812+00:00","generated_at":"2026-06-21T18:49:55.428112+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Beauty Health enters $50M revolving credit facility maturing November 2027","bullets":["Amended and restated $50M revolving credit facility with JPMorgan, maturing Nov 14, 2027.","Facility remains undrawn; no outstanding balance as of filing date.","Interest rates: Term SOFR + 1.50%-2.00% or base rate + 0.50%-1.00%.","Financial covenants: leverage ratio <= 3.00x; fixed charge coverage >= 1.15x.","Company assumed obligations from HydraFacial; LIBOR transitioned to SOFR."],"urls":{"canonical":"https://secwatch.observer/filing/0001818093-22-000177","json":"https://secwatch.observer/filing/0001818093-22-000177.json","markdown":"https://secwatch.observer/filing/0001818093-22-000177.md","text":"https://secwatch.observer/filing/0001818093-22-000177.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818093/000181809322000177/0001818093-22-000177-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818093/000181809322000177/skin-20221114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T18:49:55.428112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b0625392937950fabe7d38d9e706f33a90cd979","claim":"SkinHealth Systems Inc. amended Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. valued at $50 million revolving credit facility (effective 2022-11-14).","evidence_excerpt":"On November 14, 2022, The Beauty Health Company, a Delaware corporation (as successor by assumption to HydraFacial LLC (formerly known as Edge Systems LLC), a California limited liability company (“HydraFacial” and the “Initial Borrower”) (the “Borrower,” “Company,” “we” or “our”), as borrower, entered into an Amended and Restated Credit Agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A. (the “Administrative Agent”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818093/000181809322000177/0001818093-22-000177-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"JPMorgan Chase Bank, N.A."},{"label":"Value","value":"$50 million revolving credit facility"},{"label":"Effective","value":"2022-11-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}